A case of malignant melanoma in which adalimumab was effective for steroid‐resistant uveitis caused by dabrafenib/trametinib combination therapy

Fumi Nakano, Takanobu Kan, Yukiko Ushio, Haruna Ito, Akiko Kamegashira, Takashi Sone, Tomona Hiyama, Yosuke Harada, Akio Tanaka

Open source

DOI
10.1111/1346-8138.17594
Published
2024-12-19
Container
The Journal of Dermatology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/1346-8138.17594,
  title = {A case of malignant melanoma in which adalimumab was effective for steroid‐resistant uveitis caused by dabrafenib/trametinib combination therapy},
  author = {Fumi Nakano and Takanobu Kan and Yukiko Ushio and Haruna Ito and Akiko Kamegashira and Takashi Sone and Tomona Hiyama and Yosuke Harada and Akio Tanaka},
  year = {2024},
  journal = {The Journal of Dermatology},
  doi = {10.1111/1346-8138.17594},
  url = {https://doi.org/10.1111/1346-8138.17594}
}

RIS

TY  - JOUR
TI  - A case of malignant melanoma in which adalimumab was effective for steroid‐resistant uveitis caused by dabrafenib/trametinib combination therapy
AU  - Fumi Nakano
AU  - Takanobu Kan
AU  - Yukiko Ushio
AU  - Haruna Ito
AU  - Akiko Kamegashira
AU  - Takashi Sone
AU  - Tomona Hiyama
AU  - Yosuke Harada
AU  - Akio Tanaka
PY  - 2024
JO  - The Journal of Dermatology
DO  - 10.1111/1346-8138.17594
UR  - https://doi.org/10.1111/1346-8138.17594
ER  - 

APA

Nakano, F., Kan, T., Ushio, Y., Ito, H., Kamegashira, A., Sone, T., Hiyama, T., Harada, Y., & Tanaka, A. (2024). A case of malignant melanoma in which adalimumab was effective for steroid‐resistant uveitis caused by dabrafenib/trametinib combination therapy. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17594

Source records